Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo
- PMID: 20096608
- DOI: 10.1016/j.immuni.2009.11.010
Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo
Abstract
CD25, the high-affinity interleukin-2 (IL-2) receptor alpha chain, is rapidly upregulated by antigen-specific CD8(+) T cells after T cell receptor stimulation. Here, we demonstrate that during an acute viral infection, CD25 expression is quite dynamic-after initial upregulation, a subset of virus-specific T cells sustains CD25 expression longer than the rest. At this time when there is distinct heterogeneity in CD25 expression, examination of the in vivo fate of effector cells revealed that CD25(lo) cells, which are relatively less sensitive to IL-2, preferentially upregulate CD127 and CD62L and give rise to functional long-lived memory cells. In contrast, CD25(hi) cells perceiving prolonged IL-2 signals proliferate more rapidly, are prone to apoptosis, exhibit a more pronounced effector phenotype, and appear to be terminally differentiated. Consistent with this, sustained IL-2 receptor signaling during expansion drove terminal-effector differentiation. These data support the hypothesis that prolonged IL-2 signals during priming promote terminal-effector differentiation.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.Nat Immunol. 2003 Dec;4(12):1191-8. doi: 10.1038/ni1009. Epub 2003 Nov 16. Nat Immunol. 2003. PMID: 14625547
-
Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.Eur J Immunol. 2009 Jul;39(7):1774-83. doi: 10.1002/eji.200839093. Eur J Immunol. 2009. PMID: 19548244
-
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation.Int Immunol. 2007 Sep;19(9):1039-48. doi: 10.1093/intimm/dxm072. Epub 2007 Sep 6. Int Immunol. 2007. PMID: 17823312
-
Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination.Curr Opin Immunol. 2010 Jun;22(3):279-85. doi: 10.1016/j.coi.2010.03.008. Epub 2010 Apr 29. Curr Opin Immunol. 2010. PMID: 20434894 Review.
-
Decisions on the road to memory.Adv Exp Med Biol. 2013;785:107-20. doi: 10.1007/978-1-4614-6217-0_12. Adv Exp Med Biol. 2013. PMID: 23456843 Review.
Cited by
-
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination.Front Immunol. 2016 Sep 6;7:345. doi: 10.3389/fimmu.2016.00345. eCollection 2016. Front Immunol. 2016. PMID: 27656185 Free PMC article. Review.
-
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.Cancer Cell. 2015 Apr 13;27(4):489-501. doi: 10.1016/j.ccell.2015.03.004. Cancer Cell. 2015. PMID: 25873172 Free PMC article.
-
Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation.Front Immunol. 2020 Jul 21;11:1536. doi: 10.3389/fimmu.2020.01536. eCollection 2020. Front Immunol. 2020. PMID: 32793209 Free PMC article.
-
Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B.Immunology. 2015 Aug;145(4):543-57. doi: 10.1111/imm.12471. Epub 2015 Jun 15. Immunology. 2015. PMID: 25882552 Free PMC article.
-
IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells.J Immunol. 2012 Aug 15;189(4):1780-91. doi: 10.4049/jimmunol.1103768. Epub 2012 Jul 11. J Immunol. 2012. PMID: 22786769 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials